Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Anebulo Pharmaceuticals Inc

ANEB
Current price
1.33 USD -0.06 USD (-4.32%)
Last closed 1.57 USD
ISIN US0345691036
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 42 789 780 USD
Yield for 12 month -49.04 %
1Y
3Y
5Y
10Y
15Y
ANEB
21.11.2021 - 28.11.2021

Anebulo Pharmaceuticals, Inc., a clinical-stage biotechnology company, engages in developing treatments for unintentional cannabis poisoning, acute cannabinoid intoxication, and acute cannabis-induced conditions in the United States. Its lead product candidate is the selonabant, a small molecule antagonist of cannabinoid binding receptor type-1, which is in a phase II clinical trial to address the unmet medical need for a specific antidote for cannabis toxicity. The company was incorporated in 2020 and is based in Lakeway, Texas. Address: 1017 Ranch Road 620 South, Lakeway, TX, United States, 78734

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

6.00 USD

P/E ratio

Dividend Yield

Current Year

Last Year

Current Quarter

Last Quarter

Current Year

Last Year

Current Quarter

Last Quarter

Key Figures ANEB

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA
Operating Margin TTM
PE Ratio
Return On Assets TTM -65.97 %
PEG Ratio
Return On Equity TTM -113.80 %
Wall Street Target Price 6.00 USD
Revenue TTM
Book Value 0.15 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY
Dividend Yield
Gross Profit TTM
Earnings per share -0.32 USD
Diluted Eps TTM -0.32 USD
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics ANEB

Max Ratio

>10 - expected double digit dividend yield on cost over 10Y >5 - expected 5-9 dividend yield on cost over 10Y <5 - expected <5 dividend yield on cost over 10Y MaxRatio is an estimated 10Y dividend yield on cost calculated by combining the current dividend yield with the 5-year & 10-year average dividend growth rate, projected over the next 10 years discounted based on current Financial Score. It provides a projected outlook on future dividend returns.

5Y Dividend Growth

Consecutive Years

5Y Average Payout Ratio

Dividend History ANEB

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date
Consecutive Years
Consistent Years
Continuous Dividends

Stock Valuation ANEB

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue
Price Sales TTM
Enterprise Value EBITDA -6.54
Price Book MRQ 17.76

Financials ANEB

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators ANEB

For 52 weeks

1.25 USD 3.30 USD
50 Day MA 1.93 USD
Shares Short Prior Month 6 509
200 Day MA 2.33 USD
Short Ratio 1.94
Shares Short 6 381
Short Percent 0.28 %